Treatment of medium-sized juxtapapillary melanoma with external Co-60 photon therapy

David Roberge; Scott Nordstrom; Christine Corriveau; Micheline Gosselin; Marina Olivares; George Shenouda

doi:10.1016/j.radonc.2004.10.003

Treatment of medium-sized juxtapapillary melanoma with external Co-60 photon therapy

Radiother Oncol. 2005 Jan;74(1):71-3. doi: 10.1016/j.radonc.2004.10.003.

Authors

David Roberge¹, Scott Nordstrom, Christine Corriveau, Micheline Gosselin, Marina Olivares, George Shenouda

Affiliation

¹ Division of Radiation Oncology, McGill University, Montreal General Hospital, D5.400, 1650 Cedar Avenue, Montreal, Que., Canada H3G 1A4.

PMID: 15683673
DOI: 10.1016/j.radonc.2004.10.003

Abstract

Twenty-six patients with medium-sized juxtapapillary choroidal melanomas were irradiated using D-shaped Co-60 beams. The overall 5-year actuarial survival was 86% with a trend towards better 5-year local control with 70 vs. 60 Gy (100 vs. 75%). Of patients with pre-treatment > or =20/200 visual acuity, 37% had functional vision at 5 years.

Publication types

Clinical Trial

MeSH terms

Adult
Aged
Cobalt Radioisotopes / therapeutic use
Eye Neoplasms / pathology
Eye Neoplasms / radiotherapy*
Female
Humans
Male
Melanoma / pathology
Melanoma / radiotherapy*
Middle Aged
Photons / therapeutic use
Retrospective Studies
Survival Analysis
Visual Acuity

Substances

Cobalt Radioisotopes